Stereotaxis Announces Positive Results from First 50 Clinical Procedures Performed with New Niobe ES System.

Stereotaxis, Inc. announced the completion of the first 50 clinical procedures using the Company's new Niobe ES(TM) system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia(1). Positive initial results with the Niobe ES system in Europe demonstrate that the average time for completion of mapping and ablation for the initial AF ...

 > Read Full Story

Applications in the EP Lab: The Odyssey Cinema Studio

In this article we speak with J. Brian DeVille, MD, FACC, FHRS, cardiac electrophysiologist at THE HEART HOSPITAL Baylor Plano, which is the first in the world to implement the new Stereotaxis Epoch™ platform for use in their EP and cath labs. On December 13, THE HEART HOSPITAL Baylor Plano became the first hospital in the world to perform an electrophysiology procedure using the new Epoch™ platform. THE HEART HOSPITAL Baylor Plano is located in Plano, Texas.

 > Read Full Story

Stereotaxis Initiates Shipments of the Epoch Electrophysiology Platform.

Stereotaxis has started shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system.

 > Read Full Story

Medical Software Availability for Tablet Devices Increases As They Become More Popular

Richard Raucci Imagine you’re a busy medical professional. While walking down the corridor of the hospital on your way to surgery, you pull up information on patients you plan to see that day, including their full medical histories and up-to-the-minute vital signs. With the swipe of a finger, you bring to your screen updated and centralized procedure and visit records, then you access a patient’s realtime EKG information and dip into the hospital-wide ...

 > Read Full Story

STOPping-Ventricular Tachycardia with Stereotaxis Ablation: Interview with Electrophysiologist Dr. Zyad Younan

Ventricular tachycardia is the most common life-threatening arrhythmia, defined as a series of three or more ventricular contractions occurring at a rate of 100-250 beats per minute. VT may lead to sudden cardiac death and together with ventricular fibrillations result in an estimated 300,000 deaths per year in the United States. While acute therapeutic options include defibrillation and cardioversion, drug regimens and surgical ablation of the problematic cardiac ...

 > Read Full Story